PF
SWTX

Phoenix Financial’s SpringWorks Therapeutics SWTX Stock Holding History

Phoenix Financial’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-489,444
Closed -$13.3M – 343
2022
Q3 		$13.3M Sell
489,444
-413,423
-46% -$11.9M 0.29% 59
2022
Q2 		$22.2M Buy
902,867
+504,221
+126% +$18.4M 0.46% 62
2022
Q1 		$22.6M Buy
398,646
+89,890
+29% +$5.14M 0.38% 71
2021
Q4 		$19.1M Buy
308,756
+211,141
+216% +$14M 0.32% 80
2021
Q3 		$6.19M Buy
97,615
+36,615
+60% +$2.82M 0.11% 117
2021
Q2 		$5.03M Buy
+61,000
New +$4.63M 0.1% 149

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Phoenix Financial's SWTX Position: Q4 2022 in Review

Phoenix Financial sold out of SpringWorks Therapeutics (SWTX) in Q4 2022, closing a stake of 489,444 shares — an estimated $13.3M sold.

Phoenix Financial first reported a position in SWTX in Q2 2021 and held it in 6 quarters. The position peaked at $22.6M in Q1 2022. 137 funds tracked by Wall St. Rank hold SWTX as of Q4 2022.

  • Phoenix Financial reported no remaining SpringWorks Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Phoenix Financial sold 489,444 SpringWorks Therapeutics shares in Q4 2022, an estimated $13.3M.
  • Phoenix Financial first reported a position in SpringWorks Therapeutics in Q2 2021 and held it in 6 quarters.
  • Phoenix Financial's SpringWorks Therapeutics position peaked at $22.6M in Q1 2022.
  • 137 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2022.

Based on Phoenix Financial's 13F filing for Q4 2022, filed 13 Feb 2023.